By Dr. Shweta Agarwal, MBBS, DGO Medically reviewed by Dr. Shweta Agarwal, MBBS, DGO Last updated: June 2026
Information on this page is educational and does not replace a medical consultation. Outcomes depend on individual clinical factors.
Aansh Hospital & IVF Center is a government-registered Level-2 ART clinic (Reg. No. MH/AC/2024/15441/L2/Chandrapur/132), part of a growing chain of fertility centers across Vidarbha and northern Telangana, with our headquarters and in-house embryology lab in Chandrapur. Consultations with Dr. Shweta Agarwal are available in Marathi, Hindi, and English, and everything discussed at the appointment is strictly confidential. Our government ART registration covers the full range of regulated fertility diagnostic and treatment services.
One of the questions I hear most often — sometimes for the first time after many months of trying — is a very simple one: "Should we have come sooner?"
The honest answer is that timing matters, but it is not the same for everyone. The 12-month guideline is a reasonable starting point for couples without any known risk factors. For couples with certain histories, waiting 12 months is not the right approach. Knowing which situation you are in helps you make an informed decision rather than waiting and wondering.
This post explains the standard guidance, the age-related threshold, and the specific situations in which earlier evaluation — sometimes immediate evaluation — is the appropriate and recommended step.
What is the 12-month rule for fertility?
The 12-month rule is the widely accepted clinical threshold for when a couple should seek a formal fertility evaluation. It states that if a couple has been having regular, unprotected intercourse for 12 months without achieving a pregnancy, and the woman is under 35 years of age, a fertility assessment is recommended. This guidance is consistent with recommendations from major reproductive medicine bodies.
"Regular" in this context means approximately two to three times per week, distributed across the cycle — not timed exclusively around ovulation. "Unprotected" means without any contraception. Both conditions need to be met.
The 12-month threshold is not a diagnosis of infertility — it is a trigger for evaluation. Reaching this point does not mean something is necessarily wrong; it means the probability that investigation will find something useful is now high enough that it is worth doing. Many couples conceive during or shortly after the workup. For others, the investigation identifies a specific cause that can be addressed.
Seeking an evaluation at this point is simply a practical decision, not a sign that you have failed at anything.
Why does the threshold change to 6 months at age 35?
For women aged 35 or older, the recommended threshold for seeking evaluation is 6 months rather than 12. This is a standard adjustment, not a cause for alarm.
The reason is straightforward: ovarian reserve — the number of eggs remaining in the ovaries — declines with age, and that decline accelerates in the mid-thirties. This does not mean that women in their mid-thirties have poor fertility — many conceive without difficulty. It means that time is a more meaningful variable in this age group, and that waiting a full 12 months when 6 months would trigger the same evaluation is an unnecessary delay.
The evaluation itself is identical — the same tests are ordered for the same reasons. The only difference is the time you wait before initiating it.
For women approaching 38 or older, some specialists suggest not waiting the full 6 months and instead seeking evaluation sooner, particularly if any of the exceptions listed below also apply. This is a clinical judgment rather than a fixed rule; discussing your specific situation with Dr. Shweta Agarwal is the most useful step.
What are the exceptions — when should you see a specialist earlier regardless of time?
There are several situations in which earlier evaluation is appropriate — or in which evaluation should begin immediately, without waiting for any time threshold to pass. If any of the following apply to you or your partner, earlier evaluation is the right step.
Irregular or absent periods Irregular cycles (cycles significantly shorter than 21 days or longer than 35 days, or cycles that vary substantially from month to month) or absent periods are signs of a possible ovulation disorder. If you are not ovulating regularly, the 12-month (or 6-month) clock is not running in the usual way. PCOS is one of the most common causes of irregular ovulation and is very treatable — but it does need to be diagnosed first.
Known or suspected endometriosis Endometriosis — a condition in which tissue similar to the uterine lining grows outside the uterus — can affect fertility both structurally and through its effect on the pelvic environment. If you have been diagnosed with endometriosis, or if you have symptoms that suggest it (severe period pain, pain during intercourse, pain with bowel movements during your period), earlier evaluation is warranted. Endometriosis is best assessed and managed with a specialist, and its presence changes both the workup and the treatment approach.
Prior pelvic surgery, pelvic inflammatory disease (PID), or ectopic pregnancy Previous pelvic surgery (including appendectomy, ovarian cystectomy, myomectomy, or laparoscopy), a history of pelvic inflammatory disease, or a prior ectopic pregnancy all raise the possibility of tubal damage or adhesions that may affect the ability to conceive naturally. In these cases, tubal assessment is an important part of the workup, and waiting 12 months to find out whether the tubes are open is not in your interest.
Known male-factor history or a previous abnormal semen analysis If the male partner has had a prior semen analysis showing reduced count, motility, or morphology — or if there is a known history of testicular injury, orchitis (testicular infection/inflammation), prior groin or scrotal surgery, varicocele, or hormonal treatment — earlier evaluation is appropriate. A repeat semen analysis is a simple, non-invasive test, and knowing the male factor picture from the start is essential for planning. Male factor is involved in a significant proportion of couples presenting with fertility concerns — evaluating only one partner delays the picture.
Two or more miscarriages Recurrent pregnancy loss — generally defined as two or more clinically confirmed miscarriages — warrants specialist evaluation. This is different from difficulty conceiving; it suggests that conception may be occurring but that the pregnancy is not being sustained. The workup for recurrent loss is specific and includes tests that are not part of a standard fertility evaluation, such as antiphospholipid antibody testing, uterine structural assessment, and sometimes parental karyotyping.
Prior cancer treatment including chemotherapy or radiotherapy Certain chemotherapy agents and pelvic radiotherapy can affect both ovarian reserve and sperm production. If either partner has a history of cancer treatment, earlier evaluation allows an accurate picture of current fertility function, and in some cases fertility preservation may still be relevant to discuss.
Known uterine or ovarian conditions A known history of uterine fibroids (particularly submucosal fibroids, which can affect the uterine cavity), uterine polyps, a bicornuate or septate uterus, or ovarian conditions such as a low antral follicle count on a prior scan — any of these warrants earlier evaluation rather than waiting for a time threshold to pass.
What does "evaluation" actually involve?
Seeking an evaluation does not mean starting treatment. It means having a conversation with a specialist and undergoing the appropriate diagnostic tests. No treatment is decided before the workup results are in.
A standard fertility evaluation for most couples includes:
- For the female partner: a transvaginal ultrasound (to assess the uterus, ovarian reserve via antral follicle count, and any structural findings); a blood test for AMH (anti-Müllerian hormone, the best single marker of ovarian reserve); a Day 2–3 hormonal panel (FSH, LH, oestradiol, prolactin); thyroid function; and, at a later point when clinically appropriate, a tubal assessment (HSG or HyCoSy).
- For the male partner: a semen analysis, performed in our in-house andrology lab by Aayush Agarwal, our senior clinical embryologist, under WHO-standard conditions.
The workup is individualised — the tests ordered and the sequence will depend on your specific history and what the initial results show.
For a detailed guide to what the appointment itself involves, including what to bring and what to expect: What to expect at your first fertility consultation.
Why does evaluating both partners matter?
A male factor — abnormalities in sperm count, motility, or morphology — is a significant contributor in a substantial proportion of couples presenting with fertility concerns. This is a general population figure from the reproductive medicine literature, not a figure specific to Aansh. Evaluating only the female partner initially misses a share of relevant diagnoses and extends the time before a clear picture is available.
A semen analysis is a simple, non-invasive test. The male partner does not need to attend the first consultation in person for this component of the workup to proceed — the sample can often be arranged at an early, convenient point. But it should be part of the initial evaluation.
Treating fertility as a shared investigation from the outset — rather than a female issue first — leads to a faster and more complete diagnosis.
Does going earlier mean starting treatment sooner?
Not necessarily. Seeking an evaluation at 6 months or earlier if you have one of the exceptions above does not commit you to any treatment. Many couples who seek an evaluation find that all parameters are normal and that they are advised to continue trying for a while longer with some specific guidance. For others, a specific, treatable cause is identified quickly, and knowing it earlier is straightforwardly better than knowing it later.
The evaluation gives you information. What you do with that information is then a decision made together with your doctor, based on the actual findings — not on how long you have been trying.
There is no downside to having complete information. There can be real downsides to waiting unnecessarily when a treatable cause is present.
How do you take the first step?
If you are at the 12-month threshold, the 6-month threshold, or you recognise any of the exceptions above as relevant to your situation, the next step is a fertility assessment — a structured evaluation by Dr. Shweta Agarwal.
प्रजनन तज्ज्ञाकडे जाणे म्हणजे अपयश नाही — seeking a fertility evaluation is simply gathering the information you need to make the right decisions. It is a practical, forward-looking step.
You can book in the following ways:
- WhatsApp: +91 80056 85160 — message to arrange an appointment or ask preliminary questions
- Phone: +91 80056 85160
- Online: via the fertility assessment page
If you are not yet ready for a full consultation but want to begin with a structured initial screen, the fertility checkup is a structured entry point. If you have had a prior workup or treatment recommendation elsewhere and want an independent review, the free second opinion service is available.